GENENTA SCIENCE SPA: Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a €20 million ($21.9 million) ...
Becker's Spine Review6h
Spine surgeons’ top priorities for EHRs
When choosing an electronic health record system, spine surgeons have to consider multiple factors from efficiency, usability ...
HUTCHMED (China) Limited: HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...
CMSWire6h
Hospitals Struggle With Patient Experience. BJC HealthCare Is Fixing It
Patient experience leader Jennifer Carron explains why healthcare lags in customer experience and how real-time feedback is ...